Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nicotine 15mg inhalation cartridges with device
0410020B0AABZBZ
|
Nicotine | Nicotine | Central Nervous System | 12,187 |
|
Nicotine 21mg/24hours transdermal patches
0410020B0AAARAR
|
Nicotine | Nicotine | Central Nervous System | 10,170 |
|
Nicotine 25mg/16hours transdermal patches
0410020B0AABRBR
|
Nicotine | Nicotine | Central Nervous System | 7,565 |
|
Nicotine 15mg/16hours transdermal patches
0410020B0AAAUAU
|
Nicotine | Nicotine | Central Nervous System | 6,198 |
|
Nicorette QuickMist 1mg/dose mouthspray freshmint
0410020B0BBAZBW
|
Nicorette | Nicotine | Central Nervous System | 5,627 |
|
Nicorette invisi 25mg/16hours patches
0410020B0BBAVBR
|
Nicorette | Nicotine | Central Nervous System | 5,033 |
|
Nicotine 1mg/dose oromucosal spray sugar free
0410020B0AABWBW
|
Nicotine | Nicotine | Central Nervous System | 4,888 |
|
Nicotine 14mg/24hours transdermal patches
0410020B0AAAQAQ
|
Nicotine | Nicotine | Central Nervous System | 4,831 |
|
Nicorette 15mg Inhalator
0410020B0BBBABZ
|
Nicorette | Nicotine | Central Nervous System | 4,662 |
|
Nicotinell TTS 30 patches
0410020B0BCACAR
|
Nicotinell | Nicotine | Central Nervous System | 3,225 |
|
NiQuitin Clear 21mg patches
0410020B0BDADAR
|
NiQuitin | Nicotine | Central Nervous System | 3,067 |
|
Nicotine 10mg/16hours transdermal patches
0410020B0AAATAT
|
Nicotine | Nicotine | Central Nervous System | 2,979 |
|
Nicorette invisi 15mg/16hours patches
0410020B0BBAUAU
|
Nicorette | Nicotine | Central Nervous System | 2,803 |
|
Nicotine 2mg medicated chewing gum sugar free
0410020B0AABABA
|
Nicotine | Nicotine | Central Nervous System | 2,760 |
|
Nicotine 4mg medicated chewing gum sugar free
0410020B0AABDBD
|
Nicotine | Nicotine | Central Nervous System | 2,243 |
|
Nicotine 2mg lozenges sugar free
0410020B0AAAYAY
|
Nicotine | Nicotine | Central Nervous System | 2,137 |
|
Nicotine 7mg/24hours transdermal patches
0410020B0AAAPAP
|
Nicotine | Nicotine | Central Nervous System | 2,066 |
|
NiQuitin 21mg patches
0410020B0BDAAAR
|
NiQuitin | Nicotine | Central Nervous System | 1,848 |
|
Nicotinell TTS 20 patches
0410020B0BCABAQ
|
Nicotinell | Nicotine | Central Nervous System | 1,828 |
|
NiQuitin 14mg patches
0410020B0BDABAQ
|
NiQuitin | Nicotine | Central Nervous System | 1,235 |
|
NiQuitin Clear 14mg patches
0410020B0BDAEAQ
|
NiQuitin | Nicotine | Central Nervous System | 1,213 |
|
Nicorette QuickMist 1mg/dose mouthspray cool berry
0410020B0BBBEBW
|
Nicorette | Nicotine | Central Nervous System | 1,204 |
|
Nicorette invisi 10mg/16hours patches
0410020B0BBATAT
|
Nicorette | Nicotine | Central Nervous System | 1,182 |
|
Nicotine 4mg lozenges sugar free
0410020B0AAAZAZ
|
Nicotine | Nicotine | Central Nervous System | 1,139 |
|
Nicorette Cools 2mg lozenges
0410020B0BBBBAY
|
Nicorette | Nicotine | Central Nervous System | 987 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.